PetMed Express Files Q3 2024 10-Q

TL;DR

PETS 10-Q filed for Q3 2024. Check financials.

AI Summary

PetMed Express Inc. filed its 10-Q for the period ending December 31, 2024. The filing covers the third quarter of their fiscal year. Key financial data and operational details for this period are presented, reflecting the company's performance in the online pet pharmacy sector.

Why It Matters

This filing provides investors with an update on PetMed Express's financial health and operational performance for the critical holiday shopping quarter, impacting its stock valuation.

Risk Assessment

Risk Level: low — This is a routine quarterly filing providing standard financial and operational updates.

Key Players & Entities

• PETMED EXPRESS INC (company) — Filer of the 10-Q
• 2024-12-31 (date) — End of the reporting period
• 2025-02-10 (date) — Filing date

FAQ

Filing Documents

• pets-20241231.htm (10-Q) — 852KB
• pets-20241231xexx311.htm (EX-31.1) — 11KB
• pets-20241231xexx312.htm (EX-31.2) — 11KB
• pets-20241231xexx321.htm (EX-32.1) — 6KB
• 0001040130-25-000014.txt ( ) — 5380KB
• pets-20241231.xsd (EX-101.SCH) — 35KB
• pets-20241231_cal.xml (EX-101.CAL) — 50KB
• pets-20241231_def.xml (EX-101.DEF) — 178KB
• pets-20241231_lab.xml (EX-101.LAB) — 503KB
• pets-20241231_pre.xml (EX-101.PRE) — 339KB
• pets-20241231_htm.xml (XML) — 755KB

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS In addition to historical information, certain information in this Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended ("Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended ("Exchange Act"). All statements, other than statements of historical facts, including statements concerning our plans, objectives, goals, beliefs, business strategies, future events, business conditions, our results of operations, financial position and our business outlook, business trends and other information, may be forward-looking statements. You can identify these forward-looking statements by the words "believes," "intends," "expects," "might," "may," "will," "should," "plans," "projects," "contemplates," "intends," "budgets," "potential," "predicts," "estimates," "anticipates," "future," "goal," and variations of such words or similar expressions. These statements are based on our beliefs, as well as assumptions we have used based upon information currently available to us. Because these statements reflect our current views concerning future events, these statements involve risks, uncertainties, and assumptions, many of which, by their nature, are inherently uncertain and beyond our control. Our expectations, beliefs, estimates and projections are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that management's expectations, beliefs, estimates and projections will result or be achieved, and actual future results may differ materially from what is expressed in or indicated by the forward-looking statements. Factors that might cause such differences include, but are not limited to, those discussed in Part I, Item 1A, under the heading "Risk Factors," in our Annual Report on Form 10-K for the year ended March 31, 2024 (th

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS. PETMED EXPRESS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except for share and per share amounts) December 31, 2024 March 31, 2024 (Unaudited) ASSETS Current assets: Cash and cash equivalents $ 50,101 $ 55,296 Accounts receivable, less allowance for credit losses of $ 88 and $ 273 , respectively 2,259 3,283 Inventories, net 11,795 28,556 Prepaid expenses and other current assets 3,888 6,325 Prepaid income taxes 340 188 Total current assets 68,383 93,648 Noncurrent assets: Property and equipment, net 28,425 26,657 Intangible and other assets, net 15,035 16,503 Goodwill 26,658 26,658 Operating lease right-of-use assets 1,077 1,432 Deferred tax assets, net 5,217 4,986 Total noncurrent assets 76,412 76,236 Total assets $ 144,795 $ 169,884 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable $ 10,945 $ 37,024 Sales tax payable 24,483 25,012 Accrued expenses and other current liabilities 10,922 7,060 Current operating lease liabilities 453 459 Deferred revenue 1,156 2,603 Total current liabilities 47,959 72,158 Operating lease liabilities, net of current lease liabilities 652 995 Total liabilities 48,611 73,153 Commitments and contingencies (Note 7) Shareholders' equity: Preferred stock, $ .001 par value, 5,100,000 shares and 5,000,000 shares authorized respectively; 2,500 convertible shares issued and outstanding with a liquidation preference of $ 4 per share 9 9 Common stock, $ .001 par value, 40,000,000 shares authorized; 20,656,457 and 21,148,692 shares issued and outstanding, respectively 21 21 Additional paid-in capital 17,967 25,146 Retained earnings 78,187 71,555 Total shareholders' equity 96,184 96,731 Total liabilities and shareholders' equity $ 144,795 $ 169,884 See accompanying notes to unaudited condensed consolidated financial statements. 2 PETMED EXPRESS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF

View Full Filing

View this 10-Q filing on SEC EDGAR